Table 2.
Case # | Radiopharmaceutical | Effective clearance half-time (min) | Mean absorbed dose to infiltrated fascia (Gy) | Shallow dose equivalent to skin (Sv) |
---|---|---|---|---|
1 | 18F-FDG | 9 | 0.6 | 0.3 |
2 | 18F-FDG | 43 | 7.6 | 3.7 |
3 | 18F-FDG | 93 | 2.7 | 1.3 |
4 | 18F-FDG | 24 | 8.4 | 4.1 |
5 | 18F-FDG | 13 | 0.8 | 0.4 |
6 | 18F-FDG | 22 | 0.7 | 0.3 |
7 | 18F-FDG | 44 | 0.9 | 0.4 |
8 | 18F-FDG | 39 | 11.2 | 5.4 |
9 | 18F-FDG | 70 | 1.0 | 0.5 |
10 | 18F-FDG | 38 | 8.7 | 4.2 |
11 | 18F-FDG | 22 | 3.8 | 1.9 |
12 | 18F-FDG | 41 | 0.6 | 0.3 |
13 | 99mTc-MDP | 360 | 8.4 | < 0.1 |
14 | 18F-FDG | 46 | 1.0 | 0.5 |
15 | 99mTc-MDP | 64 | 1.5 | < 0.1 |
16 | 99mTc-MDP | 218 | 5.3 | < 0.1 |
17 | 99mTc-MDP | 38 | 0.9 | < 0.1 |
18 | 99mTc-MDP | 49 | 1.2 | < 0.1 |
19 | 99mTc-MDP | 64 | 1.5 | < 0.1 |
20 | 18F-FDG | 18 | 1.1 | 0.5 |
21 | 18F-FDG | 22 | 5.1 | 2.5 |
22 | 99mTc-MDP | 36 | 0.9 | < 0.1 |
23 | 18F-FDG | 24 | 6.8 | 3.3 |
24 | 18F-FDG | 79 | 2.9 | 1.4 |
25 | 18F-FDG | 26 | 0.8 | 0.4 |
26 | 18F-FDG | 22 | 3.6 | 1.8 |